Dear Congressman Golden, I just finished reading The Frozen Hours by Jeff Shaara, a gut-wrenching account of the thousands of ...

This perioperative approach with Imfinzi underscores our commitment to moving into earlier stages of cancer where novel ...

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

Topline results were announced from a phase 3 trial evaluating durvalumab in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

Imfinzi is one of AstraZeneca’s key growth drivers for 2025, with potential approvals in stomach and bladder cancers. The ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in ...

Results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with ...

Positive high-level results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination ...

"Matterhorn is the first phase III trial of an immunotherapy to show a statistically significant improvement in event-free survival in patients with resectable gastric and gastroesophageal junction ...

It’s a reminder of the simple pleasures in life – the joy of a perfectly baked loaf of bread, the comfort of a warm cinnamon ...

Switzerland is a land of stunning scenery, rich history, and unforgettable experiences! From the majestic Matterhorn in ...